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ABSTRACT
Introduction: People with mobility limitations can
benefit from rehabilitation programmes that provide a
high dose of exercise. However, since providing a high
dose of exercise is logistically challenging and resource-
intensive, people in rehabilitation spend most of the day
inactive. This trial aims to evaluate the effect of the
addition of affordable technology to usual care on
physical activity and mobility in people with mobility
limitations admitted to inpatient aged and neurological
rehabilitation units compared to usual care alone.
Methods and analysis: A pragmatic, assessor
blinded, parallel-group randomised trial recruiting 300
consenting rehabilitation patients with reduced mobility
will be conducted. Participants will be individually
randomised to intervention or control groups. The
intervention group will receive technology-based
exercise to target mobility and physical activity problems
for 6 months. The technology will include the use of
video and computer games/exercises and tablet
applications as well as activity monitors. The control
group will not receive any additional intervention and
both groups will receive usual inpatient and outpatient
rehabilitation care over the 6-month study period. The
coprimary outcomes will be objectively assessed
physical activity (proportion of the day spent upright)
and mobility (Short Physical Performance Battery) at
6 months after randomisation. Secondary outcomes will
include: self-reported and objectively assessed physical
activity, mobility, cognition, activity performance and
participation, utility-based quality of life, balance
confidence, technology self-efficacy, falls and service
utilisation. Linear models will assess the effect of group
allocation for each continuously scored outcome
measure with baseline scores entered as a covariate. Fall
rates between groups will be compared using negative
binomial regression. Primary analyses will be
preplanned, conducted while masked to group allocation
and use an intention-to-treat approach.
Ethics and dissemination: The protocol has been
approved by the relevant Human Research Ethics
Committees and the results will be disseminated widely
through peer-reviewed publication and conference
presentations.
Trial registration number: ACTRN12614000936628.
Pre-results.
Strengths and limitations of this study
▪ Adequately powered to detect effects on the use
of affordable technology integrated into usual
rehabilitation care on important mobility
outcomes.
▪ Technologies to enable ongoing exercise are
likely to become increasingly important in the
future as the proportion of older people in the
population increases and resources to provide
rehabilitation care become more limited.
▪ One limitation of this study is that the technology
prescription and health coaching support
requires tailoring to the individual participant,
which complicates description of the experimen-
tal intervention and the dose of intervention
delivered. Careful reporting of the technologies
prescribed, the number, mode and topics deliv-
ered during the health coaching sessions and
the use of practice sheets to record dosage of
exercise will be required to accurately communi-
cate the intervention details.
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INTRODUCTION
Mobility limitation is common in people undertaking
inpatient rehabilitation, can result from conditions such
as stroke, brain injury, hip fracture and arthritis1 and is
exacerbated by physiological ageing and inactivity.2
People with mobility limitation can beneﬁt from re-
habilitation programmes,3–5 particularly rehabilitation
programmes that contain intensive repetitive exercises.6–9
Systematic reviews of randomised trials show that higher
doses of exercise in the post-acute phase are associated
with better outcomes in people after stroke5 10 11 and
people after hip fracture3 and better fall prevention
effects in older people.12 However, observational studies
in developed countries have found that people in
rehabilitation units spend most of the day alone and
inactive, with very little time spent in activities likely to
promote recovery.13 14
New technologies potentially provide an affordable
way to increase the dose of exercise and overall physical
activity for people in rehabilitation. Exercise-based video
and computer games/exercises and activity monitors are
increasingly being used in rehabilitation settings to
provide feedback on motor performance and physical
activity. These devices (eg, Nintendo Wii, Microsoft
Kinect for Xbox, Fitbit) are relatively inexpensive
(A$80–400), widely available and have been shown to
enhance enjoyment of exercise15 16 and increase the
dose of repetitive exercise completed in rehabilitation
settings.17–21
Systematic reviews evaluating new technologies in
older adults,22 people with balance impairment23 and
stroke survivors24 25 are yet to conﬁdently determine the
effect of providing additional exercise using technology
on mobility.24 25 The majority of the studies included in
these reviews have small sample sizes and the trial
designs are either poorly reported or have a high risk of
bias. In addition, these studies typically have used only
one type of technology for all participants, limiting the
applicability of technology across a spectrum of mobility
limitations and recovery time. Some technologies tested
in studies included in these reviews would be unafford-
able for many rehabilitation units, even in more devel-
oped countries. A recent randomised feasibility study
(n=58; average age 80 years) conducted by our team
tested the addition of more affordable, tailored, video-
based and computer-based interactive exercises in add-
ition to usual care with usual care alone for people
undergoing inpatient aged and neurological rehabilita-
tion.26 This relatively brief intervention (on average 6
intervention sessions over 2 weeks) was well accepted
(86% of participants completed the intervention), safe,
enjoyable and demonstrated task-speciﬁc improvements
in balance compared to the usual care group
(between-group difference on Maximal Balance Range
test at 2 weeks after baseline adjustment was 38 mm,
95% CI 6 to 69), but did not improve overall mobility.
Although this tailored approach to delivering task-
speciﬁc repetitive exercise using a suite of technologies
appears promising, it requires rigorous evaluation with
an adequately powered randomised controlled trial. We
will now conduct such a trial after reﬁning the interven-
tion tested in our pilot trial.
The primary research question is:
1. What is the effect of the addition of affordable tech-
nology to usual care on physical activity levels
(upright time) and mobility 6 months after random-
isation in people with mobility limitations admitted
to inpatient aged and neurological rehabilitation
units compared to usual care alone?
Secondary research questions are:
1. What is the effect of the addition of affordable tech-
nology to usual care on physical activity levels and
mobility 3 weeks after randomisation in people with
mobility limitations admitted to inpatient aged and
neurological rehabilitation units compared to usual
care alone?
2. What is the effect of the addition of affordable tech-
nology to usual care on cognition (3 weeks and
6 months after randomisation), self-reported physical
activity, activity performance and participation, utility-
based quality of life, balance conﬁdence, technology
self-efﬁcacy (3 and 12 weeks and 6 months after ran-
domisation) and falls (over the 6-month period after
randomisation) in people with mobility limitations
admitted to inpatient aged and neurological rehabili-
tation units compared to usual care alone?
3. How do participants randomised to the intervention
group report the usability and enjoyment of tech-
nologies prescribed in this trial at 3 and 12 weeks
and 6 months after randomisation?
Other research questions are:
1. What is the cost-effectiveness of the intervention com-
pared to usual care over the 6-month period after
randomisation?
2. What factors predict greater use of technology for
participants randomised to the intervention group
over the 6-month period after randomisation?
3. What are the experiences of participants and staff
using affordable technology for physical rehabilitation?
METHOD
Design
A pragmatic assessor-blinded multicentre superiority
randomised controlled trial with two parallel groups
will be undertaken. The design of the trial is presented
in ﬁgure 1. The CONSORT statements for non-
pharmaceutical27 and pragmatic28 trials will be used to
guide trial conduct and will be reported according to
the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) guidelines as well as the
TIDieR framework for intervention description.29 30
Using trial data, an Incremental Cost-Effectiveness Ratio
will be calculated to assess the intervention’s relative
costs and beneﬁts in terms of gain in mobility and
quality of life. A qualitative substudy using a grounded
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theory approach with structured interviews will be con-
ducted among a subset (n=30–50) of intervention parti-
cipants and study staff.
Participants and study sites
Research physiotherapists employed for the trial will
recruit 300 inpatients from the aged and neurological
rehabilitation wards at two metropolitan hospitals in
Sydney and Adelaide, Australia; and from a metropolitan
specialised brain injury unit in Sydney, Australia. We
anticipate a total of 10 participants to be recruited every
3 weeks with different recruitment rates at each site due
to differences in bed numbers and length of stay. All
patients admitted to the study wards during the study
period will be screened for eligibility in accordance with
the inclusion and exclusion criteria. Those patients
deemed potentially eligible will continue to be screened
until they either meet eligibility or are ineligible.
Patients will be eligible for recruitment if they are at
least 18 years old; have reduced mobility (Short Physical
Performance Battery (SPPB) score of <12);31 clinician-
assessed capacity for improvement in mobility; likely life
expectancy of more than 12 months; anticipated length
of stay of ≥10 days; and an ability to maintain a standing
position with the assistance of one person as a minimum
standard.
Potential participants will be excluded if they have
cognitive impairment likely to interfere with their ability
to use the technology; insufﬁcient English language
skills to participate in the intervention and no available
interpreter; inadequate vision to use the devices;
medical condition(s) precluding exercise (unstable
cardiac disease, uncontrolled hypertension, uncon-
trolled metabolic diseases, large abdominal aortic aneur-
ysm or a weight-bearing restriction); lack of interest in
the use of the technologies; anticipated discharge to
high care residential facility or to a location too far from
study site to allow home visits and follow-up assessments.
Recruitment and allocation
A variable block randomisation schedule will be pre-
pared from a computer-generated list of random
numbers by a researcher not involved in the trial. The
randomisation schedule will incorporate stratiﬁcation for
study site and health condition (whether or not the
person has a neurological condition that affects daily
activities) and be embedded in a secure online database
(REDCap) to achieve allocation concealment. Patients
who are identiﬁed by the research physiotherapist as ful-
ﬁlling the eligibility criteria will be invited to participate.
Prior to obtaining written consent, the most recent Mini
Mental State Examination32 (MMSE) score will be
extracted from the clinical notes, or where one has not
been completed in the past week, an MMSE will be con-
ducted by the research physiotherapist to determine the
patient’s capacity to provide informed consent.
Informed consent will be sought from the eligible
patient, or by proxy from the patient’s ‘person respon-
sible’ if they score <21 on the MMSE. Once the partici-
pant gives informed consent and completes the baseline
assessment (including 24-hour activity monitoring), the
research physiotherapist will complete the randomisa-
tion process in REDCap to determine allocation to
either the intervention group (usual care+technology-
based exercise) or the control group (usual care).
Owing to the type of intervention, it will not be possible
to blind the research physiotherapist delivering the
intervention or the study participant to group allocation.
Intervention
Usual care: received by both groups
Participants in both groups will receive usual inpatient
and outpatient rehabilitation care. Usual care at the
three study sites will involve participants being assessed
by hospital-employed physiotherapists who will prescribe
a series of repetitive exercises (eg, practice of standing
up or stepping). The conduct of these exercises will be
supervised by the physiotherapists, physiotherapy assis-
tants or family members. Usual care will also include
assessment and tailored management by medical specia-
lists, nurses, occupational therapists, speech pathologists,
social workers, nutritionists, orthoptists and other health
professionals as required. At time of discharge, partici-
pants will be referred to follow-up outpatient therapy
and/or prescribed a home exercise programme in
accordance with usual practice at the study sites.
Figure 1 Trial design.
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Falls prevention information: received by both groups
All participants will be given a falls prevention bro-
chure33 focusing on safe outdoor mobility. This bro-
chure provides simple tips to assist people to be safe
when walking in the community, for example, wearing
shoes with slip-resistant soles.
Intervention group: technology-based exercise in addition to
usual care
The intervention group will receive tailored technology
use in addition to usual care. A detailed intervention
protocol has been developed to guide the tailored
technology use. The protocol includes tables that direct
the choice of technology and exercises/games based on
the participant’s mobility limitations and technology pre-
ferences. The protocol will be reviewed quarterly and
any appropriate new technologies and games/exercises
will be added throughout the trial. Table 1 shows
excerpts from the intervention protocol.
Research physiotherapists will be employed at each
site to deliver the trial intervention and will be trained
in all facets of the trial. The research physiotherapist will
determine the most appropriate intervention for each
participant based on the intervention protocol and
taking into account current impairments and mobility
limitations, participant goals, technology experience and
preferences and anticipated length of stay as determined
from a review of the clinical notes and/or discussion
with the participant’s usual hospital physiotherapist.
Each participant will be asked to use the intervention
technologies between 30 and 60 min daily for ﬁve or
more days per week, supervised and unsupervised (if
deemed safe to do so) in addition to usual care. The
total duration of the intervention will be 6 months after
randomisation and will incorporate inpatient rehabilita-
tion and post-discharge settings. Figure 2 provides a ﬂow
diagram of the experimental intervention delivery.
The prescription of technology to target mobility and
physical activity problems will include, but will not be
limited to, the use of video and computer games and
tablet applications to encourage structured exercise and
other forms of physical activity as well as activity moni-
tors to provide feedback on physical activity levels. The
chosen technologies include recreational commercially
available devices (eg, Fitbit, Fitbit Inc, San Francisco,
California, USA) and rehabilitation-speciﬁc devices (eg,
Humac balance system, CSMi Solutions, Stoughton,
Massachusetts, USA). All technologies are relatively low
cost (ranging from no cost (Runkeeper app) to A$4000
(Stepping Tiles)), provide feedback on mobility task or
physical activity performance or dose, and facilitate indi-
vidualised tailoring and progression of exercise or phys-
ical activity. The technologies were identiﬁed through
knowledge and previous use by the investigators26 and
internet and literature searches of technologies being
used and developed for rehabilitation. In addition, tech-
nologies were developed by the research team speciﬁc-
ally for the trial. Technologies identiﬁed were trialled
and tested by experienced rehabilitation physiotherapists
(LH, KS and DT) and by our consumer representative
(RP) who provided feedback on the usability, feedback
and enjoyment of the technologies.
While in hospital, the research physiotherapist will ini-
tially provide one-on-one supervision to ensure safety
and to help participants learn to use the technologies
outside of therapy times. Participants will be encouraged
to exercise with family/friends or alone, if and when
they are judged safe to do so; however, the research
physiotherapist will still monitor the sessions to ensure
that the prescribed dose is delivered. The amount of
assistance required and the time taken to learn to inde-
pendently use the different technologies will be
recorded by the research physiotherapist.
After discharge from the inpatient stay, participants
will be encouraged to continue using the technologies
at home. Participants will be loaned necessary equip-
ment (stand-alone devices or game consoles, which will
be installed by study staff) and trained in the safe use
and progression of the games/exercises during a home
visit by the research physiotherapist. Support will be pro-
vided by the research physiotherapist every 1–2 weeks
using a tailored health coaching approach via telephone,
email, home visit or videoconference. This support will
aim to assist study participants to maintain motivation to
continue to use the technologies to improve mobility
and physical activity, to identify and address any barriers
to technology use at home and to identify the need to
modify the program/technology to make it more or less
challenging.
Goals will be set collaboratively with each participant
and will be recorded and reviewed throughout the inter-
vention phase. Practice recording sheets and informa-
tion from some of the devices (eg, game play time,
number of steps walked) will be used to monitor the
dose of the intervention. Intervention ﬁdelity will be
monitored via random audits of data forms and observa-
tion of intervention sessions by the trial manager.
Regular team meetings will be conducted to discuss
intervention delivery and the results of ﬁdelity checking.
Outcome measures
The coprimary outcomes will be physical activity (propor-
tion of the day spent upright) and mobility (SPPB)
6 months after randomisation. Secondary outcomes will be
physical activity and mobility (3 weeks after randomisation),
cognition (3 weeks and 6 months after randomisation), self-
reported physical activity, activity performance and partici-
pation, utility-based quality of life, balance conﬁdence,
technology self-efﬁcacy (3 and 12 weeks and 6 months after
randomisation), falls and service utilisation in the 6 months
after randomisation. In addition, self-reported measures of
technology usability and enjoyment will be obtained from
the intervention group (3 and 12 weeks and 6 months after
randomisation). All outcomes (excluding activity per-
formance and participation and self-reported physical
activity) as well as demographic information such
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Table 1 Excerpts from the tables within the intervention protocol of various games/exercises from different technologies
recommended for use with different mobility limitations
Mobility task
problem
Easy technology: game or
exercise
Medium technology: game
or exercise
Hard technology: game or
exercise
Standing Up
weight borne principally
through intact side
Humac*: weight-bearing;
scale;
Fysiogaming†: sit to stand
(1–10);
Stepping Tiles‡: loading the
leg in sitting
Humac: progress difficulty
level and boundaries of
movement;
Fysiogaming: sit to stand
(11–20);
Stepping Tiles: sit to stand
Humac: force vs time;
Fysiogaming: sit to stand
(21–30);
Stepping Tiles: sit to stand
Maintaining a standing
position
decreased loading of the
affected leg
Humac: weightshift ML;
WiiFit§: Penguin slide
(modified);
T-Rex iPAD APP¶: standing
exercises
Humac: targets, roadway, ski;
WiiFit: table tilt, ski slalom,
heading, balance bubble
WiiFit: tightrope, tilt city;
Humac: pong ML, breakout
ML;
Xbox kinect your shape
fitness evolve 2012: stack
em up
Reaching in standing
flexes at hips instead of
DF at ankles when
reaching forward
Humac: weightshift AP;
Fysiogaming: reaching
(1–10);
AMOUNT iPAD APP**:
reaching in standing program
Humac: progress difficulty
level and boundaries of
movement;
Xbox kinect†† adventures:
20 000 leaks
Humac: progress difficulty
level and boundaries of
movement;
Fysiogaming: reaching
(21–30)
Stepping while standing
decreased speed of
stepping
Fysiogaming: walking
sideways and walk in place
(1–10);
Stepping Tiles: stepping
exercise (small);
Wii Family trainer: sprint
challenge
WiiFit: jogging plus;
Xbox kinect adventures:
space pop, 20 000 leaks;
Stepping Tiles: stepping
exercise (large)
WiiFit: Cycling, step basic;
Xbox kinect: river rush, rally
ball, reflex ridge;
Fysiogaming: walking
sideways and walk in place
(21–30)
Changing directions
while walking
shuffling feet to change
direction
Stepping Tiles: stepping grid
(small)
AMOUNT iPAD APP:
changing directions while
walking program;
Fysiogaming: dynamic
balance random (1–10)
Stepping Tiles: stepping grid
(large);
Fysiogaming: dynamic
balance random (11–20);
Xbox kinect: stomp it
(modified);
Wii Family trainer: mole
stomper
AMOUNT iPAD APP:
changing directions while
walking program;
Fysiogaming: dynamic
balance random (level
21–30);
Xbox kinect: stomp it
Stair climbing
decreased hip and knee
extension when ascending
stairs
Stepping Tiles: Stepping
up and down on a block;
iPAD APP: AMOUNT
Climbing stairs program;
Fitbit‡‡: floors climbed
WiiFit: step basic (modified)
Fitbit: floors climbed
Stepping Tiles: as for easy
but increase height of block
WiiFit: step basic
Fitbit: floors climbed
iPAD APP: AMOUNT
Climbing stairs program
Physical activity
throughout the day
prolonged periods of sitting
Any technology used in
standing
Any technology used in
standing;
Activity Monitors: Fitbit one/
zip, Garmin vivofit§§;
AMOUNT iPAD APP:
Physical activity throughout
the day program
Any technology used in
standing;
Activity Monitor: Fitbit one/
zip, Garmin vivofit;
Smartphone APPs:
Runkeeper¶¶
*Humac balance system, CSMi Solutions, Stoughton, Massachusetts, USA.
†Fysiogaming, Doctor Kinetic, Amsterdam, the Netherlands.
‡Stepping Tiles, University of Technology Sydney, Sydney, Australia.34
§Nintendo WiiFit, Nintendo, Kyoto, Japan.
¶T-Rex iPAD APP, Repatriation General Hospital, Adelaide, Sydney, Australia.
**AMOUNT iPAD APP The George Institute for Global Health, Sydney, Australia.
††Xbox Kinect, Microsoft Redmond Campus, Redmond, Washington, USA.
‡‡Fitbit, Fitbit Inc, San Francisco, California, USA.
§§Garmin Ltd, Olathe, Kansas, USA.
¶¶Runkeeper, FitnessKeeper, Boston, Massachusetts, USA.
AP, anteroposterior; DF, Dorsiflexion; ML, mediolateral.
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as age and sex, diagnosis, existence of comorbidities
(Functional Comorbidity Index)35 and cognitive status
(MMSE)32 will be assessed at baseline (prior to random-
isation) to enable a description of the sample’s baseline
characteristics and to obtain values to enter as covariates
in the models comparing groups at follow-up.
All outcomes will be assessed by a research staff
member who will be trained in the conduct of the
outcome assessment and who is unaware of group
allocation. Prior to the follow-up assessments, partici-
pants will be instructed not to inform the assessor of
their group assignment. Follow-up assessments at 3 weeks
and 6 months will be conducted in the hospital or in
participants’ homes where necessary and will involve
performance-based tests and questionnaires. Follow-up
assessments at 12 weeks will be conducted by mail or
phone and will involve questionnaires only. If an assessor
becomes unblinded during the 3-week or 12-week assess-
ment, every effort will be made to use a different blinded
assessor for the remaining assessments. Regardless of
adherence to the intervention protocol, every effort will
be made to collect outcome data at all time periods for
all participants, unless the participant wishes to withdraw
from the study.
Coprimary outcomes
Physical activity has been operationalised as the propor-
tion of the day spent upright. It will be assessed over a
7-day period using the activPAL activity monitor (PAL
Technologies Ltd, Glasgow, UK) at baseline (24-hour
monitoring), and at 3 weeks and 6 months postrandomi-
sation. The activPAL is a small lightweight sensor attached
to the thigh with thin transparent wound dressing mater-
ial. This device has been used extensively in rehabilitation
settings and accurately measures sitting time,36 walking37
and total upright time.38 Using proprietary algorithms,
the activPAL classiﬁes an individual’s activity into periods
spent sitting, standing and walking. The proportion of the
day spent upright at 6 months will be the primary
outcome (and the 3-week measure a secondary outcome).
Mobility will be measured using the continuously
scored version39 (0–3) of the SPPB.31 The SPPB is a
composite performance-based measure of gait, sit-
to-stand and standing balance which predicts institution-
alisation and death.31 40 It involves measurement of time
taken to stand up from a chair ﬁve times, time taken to
walk 4 m and timed ability to stand unsupported with the
feet in three different positions of increasing difﬁculty
(feet together, semitandem and tandem). The 6-month
continuously scored SPPB will be the primary outcome
measure (and the 3-week data and the total score (0–12)
and subscale scores (0–4) as secondary measures).
Secondary outcomes
Self-reported physical activity will be measured with
the Incidental and Planned Exercise Questionnaire
(IPEQ).41 The IPEQ covers the frequency and duration
of planned and incidental physical activity in older
people and has excellent psychometric properties to
assess physical activity relating to both basic and more
demanding activities.
The de Morton Mobility Index (DEMMI)42 will be used
as a secondary measure of ‘mobility’. The DEMMI is a
15-item hierarchical measure that covers the mobility spec-
trum from bed mobility to high-level independent mobility
and has been shown to accurately measure and monitor
the mobility of older adults across acute, subacute and
community settings.42–44 In addition, mobility will also be
measured using a timed single leg stance (maximum
30 s), Maximal Balance Range Test45 and Step Test.46
Self-reported activity performance and participation
will be measured using the WHO Disability Assessment
Schedule 2.0 (WHODAS 2.0).47 The WHODAS 2.0 is a
brief 12-item summed self-report measure of activity per-
formance and participation in the prior month covering
the six domains of (1) Understanding and communica-
tion; (2) Self-care; (3) Mobility (getting around); (4)
Interpersonal relationships (getting along with others);
(5) Work and household roles (life activities); and (6)
Community and civic roles (participation). The
WHODAS 2.0 has high internal consistency and test–
retest reliability and good concurrent validity with other
measures of disability.47 48 In addition, conﬁdence in per-
forming various ambulatory activities without falling or
experiencing a sense of unsteadiness will be measured
with the Activities-Speciﬁc Balance Conﬁdence Scale.49
Figure 2 Flow of delivery of experimental intervention.
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Cognition: will be assessed using the Trail Making Test
(TMT) parts A and B.50 51 This test provides information
on scanning, visual search, speed of processing, mental
ﬂexibility and executive function.51 TMT part A involves
participants drawing to connect 25 consecutive numbers
(eg, 1-2-3) and part B involves participants drawing to
connect alternating letters and numbers (eg, 1-A-2-B).
The difference in time taken to complete each part (B
minus A) will be calculated to isolate the executive func-
tioning component of this test.
Utility-based quality of life: will be assessed using the
Short Form 6-dimensions questionnaire (SF-6D) calculated
from the SF-3652 and the EuroQol 5-dimensions
(EQ5D-5L).53 Both of these measures provide a single
index value for health and enable determination of quality
adjusted life years (QALYs) for use in cost utility analysis.
Falls and health and community service usage: will be
assessed over the 6-month period after randomisation.
Data will be collected during the inpatient stay using
study site incident documentation systems and hospital
databases. After discharge, participants will be asked to
complete monthly calendars for the remainder of the
trial documenting any falls and service usage. Recorded
falls will be followed up by a phone call from a blinded
assessor to document information about the fall (eg,
location, time). Data will be obtained by phone from
participants who are unable or unwilling to complete a
calendar.
Technology self-efﬁcacy: will be measured using the
Modiﬁed Computer Self Efﬁcacy Scale.54 Exposure to
common technologies (eg, smartphone, computer) in
the month prior to hospitalisation and during their
inpatient and community components of the trial will
be measured using a purposely designed questionnaire.
For participants in the intervention group, we will also
assess their impression of the ‘usability’ and ‘enjoyment’
of different technologies using the System Usability
Scale55 56 and Physical Activity Enjoyment Scale.57 In add-
ition, adherence to the intervention will be calculated
using records kept by staff, usage diaries kept by partici-
pants and data available from the devices themselves.
Adverse events (minor and serious) will be monitored
throughout the trial and any adverse events will be
reported to the trial Data Monitoring Committee, which
is independent from the Investigator team and has no
competing interests. For this trial, an adverse event is
deﬁned as an unwanted and usually harmful outcome
(eg, fall, seizure, cardiac event). The event may or may
not be related to the intervention, but it occurs while
the person is participating in the intervention, that is,
while they are undertaking mobility or physical activities
using technology.
Data analysis and management
Sample size
A total of 300 participants (150 per group) will provide
90% power to detect as signiﬁcant, at the 5% level, a
15% between-group difference in the coprimary
outcome measures. The sample size calculation was
undertaken using the sampsi command in Stata V.13
using data from our pilot study26 and unpublished data
from a previous study in inpatient rehabilitation.58 The
calculation assumed one pre-randomisation measure,
one follow-up measure, analysis using linear models with
baseline scores entered as covariates and a correlation
between premeasures and postmeasures of 0.65. For
the continuously scored SPPB score, the intervention
group mean was assumed to be 1.89, the control group
mean 1.64 and the SD 0.75. For the activPAL, the in-
tervention group upright minutes per day was assumed
to be 223, the control group mean 194 and the SD 90.
We have conservatively allowed for a 20% dropout
rate. This sample size will also be sufﬁcient to detect
between-group differences of 10–15% in most of the sec-
ondary outcomes.
Data management
All primary and secondary outcome data will initially be
collected on paper data forms (and stored securely) and
then entered into the secure online REDCap database.
User roles and Data Access Groups have been created in
REDCap to ensure that staff who are conducting
outcome assessments remain blinded to group allocation
when entering data into the database. Where feasible,
data ﬁelds within REDCap have criteria assigned (eg, set
range of values) as a double check that valid data are
entered into each data ﬁeld. In addition, 10% of the
data entered will be double-checked as part of the data
cleaning process.
Analysis of outcomes
Between-group comparisons for each of the continu-
ously scored outcome measures will be made using
linear models with baseline scores entered as a covariate.
The dichotomous outcomes will be compared between
groups using log binomial regression. Fall rates between
groups will be compared using negative binomial regres-
sion. Interaction terms will be used in the models to
assess whether effects of the intervention differed accord-
ing to age or a neurological versus non-neurological
cause of the mobility limitation. Primary analyses will be
preplanned, conducted while masked to group allocation
and use an intention-to-treat approach. All analyses will
be overseen by the study statistician (SH).
Health and community service usage data collected
from participant-completed calendars, hospital databases
and medical records (length of stay, procedures, reasons
for readmission or emergency department visit) will be
used to calculate health service utilisation and costs to
inform the conduct of an economic evaluation. The cost
of the intervention (staff and equipment) will also be
calculated from trial records and used in the cost-
effectiveness analysis. The Incremental Cost-Effectiveness
Ratio will be calculated to assess the relative costs and
beneﬁts in terms of gain in mobility (SPPB score
Hassett L, et al. BMJ Open 2016;6:e012074. doi:10.1136/bmjopen-2016-012074 7
Open Access
group.bmj.com on September 14, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
change) and quality of life (using the SF-6D and the
EQ5D-5L).
ETHICS AND DISSEMINATION
The results of this trial will be disseminated via presenta-
tions at local, national and international conferences,
peer-reviewed journals and via Investigator institutional
websites and media departments.
DISCUSSION
The pragmatic trial design has the advantage that we are
testing this intervention in the real world and as such, if
found effective, is ready to be implemented in clinical
practice. However, the potential limitations of the study
include the individualised tailoring of the intervention,
the risk of contamination with control and intervention
participants on the same wards and the reliance on par-
ticipant self-report of dosage for the community compo-
nent of the intervention. These potential limitations will
be addressed by a detailed intervention protocol to
guide delivery of the intervention, trial technologies
only accessible to research staff on the wards and the
addition of dosage data from some technologies (eg,
step count from the Fitbit; game play time from the
Nintendo Wii) to support the self-report data.
This study will be the ﬁrst trial of tailored exercise
using affordable technology integrated with usual
rehabilitation care to be adequately powered to detect
effects on important mobility outcomes. The signiﬁ-
cance of this study is in the potential for widespread tai-
lored use of these technologies in rehabilitation to
increase the dose of repetitive exercise without dramatic
increases in staff costs and thus enhance outcomes in a
cost-effective manner. Technologies to enable ongoing
exercise are likely to become increasingly important in
the future as the proportion of older people in the
population increases and resources to provide rehabilita-
tion care become more limited.
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